BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 21, 2004
View Archived Issues
Perlegen and Pfizer to analyze drug response in patients with major depression
Read More
Cypress Bioscience, Forest and Pierre Fabre announce agreement for milnacipran
Read More
HemispheRx and Vanderbilt University announce joint SARS clinical program
Read More
Metabasis Therapeutics announces collaboration to develop treatments for hepatitis C
Read More
Purdue Pharma files petition with FDA for generic forms of OxyContin
Read More
Gefitinib shows promise in the treatment of recurrent glioblastoma
Read More
Protective effects against UV irradiation reported for topical lycopene
Read More
Cell type-specific metabolism of testosterone in human skin
Read More
Acumen and Merck team to develop drugs for Alzheimer's disease
Read More
AnorMED expands Fosrenol licensing agreement
Read More
Boehringer Ingeheim claims new glucocorticoid receptor modulators and their use
Read More
Novel NHE-1 inhibitors in early development at Aventis
Read More
New HCV NS5B inhibitors identified at NeoGenesis
Read More
Chinese researchers design dual 5-HT/NA reuptake inhibitors for use as antidepressants
Read More
MediGene names Yamanouchi as pan-European partner for prostate cancer products
Read More
Corixa and GSK Bio to commence phase I study of tuberculosis vaccine
Read More
Aventis claims new NHE-3 inhibitors for sleep apnea and other disorders
Read More
Genzyme presents new kallikrein/urokinase inhibitors for pain, inflammation and cancer
Read More
Studies support antiinflammatory and antiatherosclerotic effects of PPARgamma agonist
Read More
AVE-7688 reduces nephropathy in type 2 diabetes
Read More
Pharmacological profile of 5-HT2C agonist YM-348
Read More
Development of an improved orally active 5-lipoxygenase inhibitor
Read More
Novel mixed opioid analgesic with limited effects on respiratory function
Read More
Roche submits European MAA for MabThera
Read More
Eloxatin submitted for adjuvant treatment of colon cancer in U.S. and Europe
Read More
New phase II trial of Trovax in colorectal cancer cleared to begin in U.K.
Read More
Taxotere approved in Japan for esophageal cancer
Read More
HER-2 Protein AutoVac induces antibody responses in breast cancer trial
Read More
First world launch of Pfizer's antifungal agent fosfluconazole in Japan
Read More